AXIM Biotechnologies, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2019 | 95.4% | 95.4% | -381.1% |
| FY2020 | -409.4% | -409.4% | -56.7% |
| FY2021 | 685.7% | 685.7% | -301.2% |
| FY2022 | 129.4% | 129.4% | -148.2% |
| FY2023 | 105.3% | 105.3% | -195.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2019 | 95.4% | 95.4% | -381.1% |
| FY2020 | -409.4% | -409.4% | -56.7% |
| FY2021 | 685.7% | 685.7% | -301.2% |
| FY2022 | 129.4% | 129.4% | -148.2% |
| FY2023 | 105.3% | 105.3% | -195.5% |